abrdn Life Sciences Investors (HQL)

Price$16.92

Value ScoreD

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-12.17%

Price vs S&P 500 (4W)-6.97%

VGM Score49.03

Market Capitalization$522.56M

P/E Ratio (Annual)6.15x

All Metrics

Book Value / Share (Quarterly)$13.66

Indicated Dividend (Annual)$2.04

Revenue Growth (3Y)1.06%

Cash Flow / Share (Quarterly)$-1.29

Price vs S&P 500 (YTD)-7.32%

Gross Margin (TTM)-35.92%

Net Profit Margin (TTM)651.52%

EPS (TTM)$-0.41

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-0.41

Revenue Growth (5Y)11.95%

EPS (Annual)$3.04

ROI (Annual)18.48%

Gross Margin (Annual)-35.76%

Net Profit Margin (5Y Avg)146.89%

Cash / Share (Quarterly)$0.00

Revenue Growth QoQ (YoY)-0.66%

P/E Normalized (Annual)6.15x

ROA (Last FY)18.44%

Revenue Growth TTM (YoY)15.88%

EBITD / Share (TTM)$-0.05

ROE (5Y Avg)7.10%

Operating Margin (TTM)-62.01%

Cash Flow / Share (Annual)$-2.77

P/B Ratio1.32x

P/B Ratio (Quarterly)0.93x

EV / Revenue (TTM)149.32x

Net Interest Coverage (TTM)-0.03x

ROA (TTM)-2.75%

EV / EBITDA (TTM)6.10x

EPS Incl Extra (Annual)$3.04

Current Ratio (Annual)0.32x

Quick Ratio (Quarterly)0.42x

3-Month Avg Trading Volume0.11M

52-Week Price Return35.04%

P/S Ratio (Annual)149.35x

Asset Turnover (Annual)0.01x

52-Week High$18.46

Operating Margin (5Y Avg)-104.45%

EPS Excl Extra (Annual)$3.04

26-Week Price Return-4.24%

Quick Ratio (Annual)0.27x

13-Week Price Return6.35%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.42x

Enterprise Value$522.56M

Revenue / Share Growth (5Y)8.02%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-0.13%

Pretax Margin (Annual)638.85%

Cash / Share (Annual)$0.00

3-Month Return Std Dev23.11%

Gross Margin (5Y Avg)-74.32%

ROE (Last FY)18.48%

Net Interest Coverage (Annual)-0.08x

EPS Basic Excl Extra (Annual)$3.04

P/FCF (TTM)13.13x

EV / Free Cash Flow (TTM)47.08x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.41

ROI (TTM)-2.80%

P/S Ratio (TTM)149.32x

Pretax Margin (5Y Avg)146.89%

Revenue / Share (Annual)$0.13

Price vs S&P 500 (52W)10.67%

Year-to-Date Return0.83%

5-Day Price Return-3.86%

EPS Normalized (Annual)$3.04

ROA (5Y Avg)7.25%

Net Profit Margin (Annual)638.85%

Month-to-Date Return-5.26%

EBITD / Share (Annual)$-0.20

EPS Growth (3Y)5.09%

Operating Margin (Annual)-62.18%

ROI (5Y Avg)7.10%

EPS Basic Excl Extra (TTM)$-0.41

P/B Ratio (Annual)0.90x

Pretax Margin (TTM)651.52%

Book Value / Share (Annual)$16.43

Price vs S&P 500 (13W)-1.91%

Net Margin Growth (5Y)-15.00%

Beta0.74x

P/FCF (Annual)55.01x

Revenue / Share (TTM)$0.13

ROE (TTM)-2.80%

52-Week Low$12.34

vGradeD

gGradeC

mGradeC

vgmGradeC

Show chart for

About

abrdn Life Sciences Investors is a non-diversified, closed-end fund focused on long-term capital appreciation in the life sciences sector. It invests in both public and private companies with above-average growth potential. The fund's strategy targets companies believed capable of delivering superior returns.